Advanced Medical Solutions (LSE:AMS) reported record financial results for 2025, with group revenue rising 29% to £228.9 million and adjusted EBITDA increasing 24% to £49.9 million. The performance was supported by strong organic growth alongside the first full-year contribution from the Peters Surgical acquisition.
The Surgical division delivered particularly strong momentum, with sales climbing 36% at constant currency to £183.5 million. Growth was driven by double-digit increases across key product categories including LiquiBand surgical adhesives, biosurgical devices and suture-related products. Meanwhile, the Advanced Woundcare segment recorded 9% growth as restructuring measures began to improve performance.
Management highlighted the successful integration of both the Peters Surgical and Syntacoll acquisitions. Early commercial synergies have already contributed to increased sales, while additional operational synergies are expected to be realised from 2027. The company also pointed to a strong innovation pipeline covering surgical adhesives, sutures, collagen technologies and bone substitute products.
Despite continued investment in manufacturing transformation initiatives, net debt declined to £50.5 million. Reflecting confidence in the group’s financial position, the board proposed a 10% increase in the dividend. Looking ahead, management expects both revenue and EBITDA in 2026 to meet current market forecasts, supported by sustained strength in the Surgical division and more modest growth in Advanced Woundcare.
Advanced Medical Solutions’ outlook reflects a combination of strong revenue growth and a solid balance sheet, although some pressure on profitability margins remains a challenge. Technical indicators suggest a generally positive share price trend, but valuation metrics imply the stock may already reflect much of the growth potential. Recent corporate developments, including strategic acquisitions and continued engagement with investors, underline the company’s long-term expansion strategy.
More about Advanced Medical Solutions
Advanced Medical Solutions Group is a UK-based medical technology company specialising in tissue-healing solutions for surgical and advanced wound care applications. Its product portfolio includes skin adhesives and sealants, biosurgical devices, sutures, clips and collagen-based materials. The company serves healthcare markets worldwide through a combination of direct sales channels and strategic partnerships, with a growing global footprint in surgical and woundcare technologies.
Leave a Reply